Early Recurrence and Cerebral Bleeding in Patients With Acute Ischemic Stroke and Atrial Fibrillation
Stroke2015Vol. 46(8), pp. 2175–2182
Citations Over TimeTop 1% of 2015 papers
Maurizio Paciaroni, Giancarlo Agnelli, Nicola Falocci, Valeria Caso, Cecilia Becattini, Simona Marcheselli, Christina Rueckert, Alessandro Pezzini, Loris Poli, Alessandro Padovani, László Csiba, Lilla Szabó, Sung‐Il Sohn, Tiziana Tassinari, Azmil H. Abdul‐Rahim, Patrik Michel, Maria Cordier, Peter Vanacker, Suzette Rémillard, Andrea Alberti, Michele Venti, Umberto Scoditti, Licia Denti, Giovanni Orlandi, Alberto Chiti, Gino Gialdini, Paolo Bovi, Monica Carletti, Alberto Rigatelli, Jukka Putaala, Turgut Tatlisumak, Luca Masotti, Gianni Lorenzini, Rossana Tassi, Francesca Guideri, Giuseppe Martini, Georgios Tsivgoulis, Kostantinos Vadikolias, Chrissoula Liantinioti, Francesco Corea, Massimo Del Sette, Walter Ageno, Maria Luisa De Lodovici, Giorgio Bono, Antonio Baldi, Sebastiano D’Anna, Simona Sacco, Antonio Carolei, Cindy Tiseo, Monica Acciarresi, Cataldo D’Amore, Davide Imberti, Dorjan Zabzuni, Б. М. Доронин, Vera Volodina, Domenico Consoli, Franco Galati, Alessio Pieroni, Danilo Toni, Serena Monaco, Mario Maimone Baronello, Kristian Barlinn, Lars‐Peder Pallesen, Jessica Kepplinger, Ulf Bodechtel, Johannes Gerber, Dirk Deleu, Gayane Melikyan, Faisal Ibrahim, Naveed Akhtar, Maria Giulia Mosconi, Valentina Bubba, Ilenia Silvestri, Kennedy R. Lees
Abstract
Acute stroke in atrial fibrillation patients is associated with high rates of ischemic recurrence and major bleeding at 90 days. This study has observed that high CHA2DS2-VASc score, high National Institutes of Health Stroke Scale, large ischemic lesions, and type of anticoagulant administered each independently led to a greater risk of recurrence and bleedings. Also, data showed that the best time for initiating anticoagulation treatment for secondary stroke prevention is 4 to 14 days from stroke onset. Moreover, patients treated with oral anticoagulants alone had better outcomes compared with patients treated with low molecular weight heparins alone or before oral anticoagulants.
Related Papers
- → Stroke prevention in atrial fibrillation(2016)463 cited
- → Modified Rankin scale as a determinant of direct medical costs after stroke(2017)59 cited
- → Risk of stroke and transient ischaemic attack in patients with a diagnosis of resolved atrial fibrillation: retrospective cohort studies(2018)52 cited
- → Incidence, clinical features and outcomes of atrial fibrillation and stroke in Qatar(2019)19 cited
- → Clinical Characteristics, Management, and Control of Permanent vs. Nonpermanent Atrial Fibrillation: Insights from the RealiseAF Survey(2014)11 cited